Tema ETFs · 2023-11-20 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$1.2M | — | — | $54.0M | 每日估算 |
| 2026-07-30 | +$1.1M | — | — | $55.7M | 每日估算 |
| 2026-07-29 | -$483,124 | — | — | $54.8M | 每日估算 |
| 2026-07-28 | +$48,532 | — | — | $54.5M | 每日估算 |
| 2026-07-27 | -$231,608 | — | — | $54.0M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
LLY Eli Lilly & Co | EC | 5,263 | $5.5M | 10.01% |
RHHBY Roche Holding AG | EC | 50,740 | $3.0M | 5.46% |
JNJ Johnson & Johnson | EC | 10,810 | $2.7M | 4.85% |
AZN AstraZeneca PLC | EC | 12,706 |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | -$425,949 | — | — | $54.0M | 每日估算 |
| 2026-07-25 | -$232,437 | — | — | $54.2M | 每日估算 |
| 2026-02-28 | -$2.1M | $0 | $2.1M | $55.3M | SEC 月度 |
| 2026-01-31 | +$1.4M | $1.4M | $0 | — | SEC 月度 |
| 2025-12-31 | +$2.8M | $2.8M | $0 | — | SEC 月度 |
| $2.7M |
| 4.81% |
MRK Merck & Co Inc | EC | 18,918 | $2.3M | 4.23% |
TMO Thermo Fisher Scientific Inc | EC | 4,137 | $2.2M | 3.90% |
UNH UnitedHealth Group Inc | EC | 7,253 | $2.1M | 3.85% |
GILD Gilead Sciences Inc | EC | 13,435 | $2.0M | 3.62% |
NOVN Novartis AG | EC | 11,781 | $2.0M | 3.61% |
ABT Abbott Laboratories | EC | 16,017 | $1.9M | 3.37% |
VRTX Vertex Pharmaceuticals Inc | EC | 3,568 | $1.8M | 3.20% |
ABBV AbbVie Inc | EC | 7,045 | $1.6M | 2.96% |
DHR Danaher Corp | EC | 7,657 | $1.6M | 2.92% |
BSX Boston Scientific Corp | EC | 17,749 | $1.4M | 2.47% |
MDT Medtronic PLC | EC | 13,377 | $1.3M | 2.36% |
BBIO Bridgebio Pharma Inc | EC | 18,567 | $1.2M | 2.23% |
RVMD Revolution Medicines Inc | EC | 11,995 | $1.2M | 2.21% |
BMY Bristol-Myers Squibb Co | EC | 19,189 | $1.2M | 2.16% |
MCK McKesson Corp | EC | 1,210 | $1.2M | 2.16% |
NOVOB Novo Nordisk A/S | EC | 31,589 | $1.2M | 2.15% |
AMGN Amgen Inc | EC | 2,984 | $1.2M | 2.09% |
4519 Chugai Pharmaceutical Co Ltd | EC | 16,971 | $1.1M | 2.05% |
REGN Regeneron Pharmaceuticals Inc | EC | 1,426 | $1.1M | 2.01% |
EW Edwards Lifesciences Corp | EC | 11,887 | $1.0M | 1.86% |
TEVA Teva Pharmaceutical Industries Ltd | EC | 26,392 | $893,633 | 1.62% |
CYTK Cytokinetics Inc | EC | 13,108 | $815,580 | 1.47% |
ISRG Intuitive Surgical Inc | EC | 1,610 | $810,651 | 1.47% |
MASI Masimo Corp | EC | 4,286 | $751,550 | 1.36% |
DXCM Dexcom Inc | EC | 9,698 | $712,124 | 1.29% |
MDGL Madrigal Pharmaceuticals Inc | EC | 1,551 | $670,032 | 1.21% |
INSM Insmed Inc | EC | 4,417 | $659,591 | 1.19% |
ALNY Alnylam Pharmaceuticals Inc | EC | 1,972 | $656,518 | 1.19% |
PODD Insulet Corp | EC | 2,336 | $576,081 | 1.04% |
ARWR Arrowhead Pharmaceuticals Inc | EC | 8,970 | $567,532 | 1.03% |
VKTX Viking Therapeutics Inc | EC | 13,867 | $469,259 | 0.85% |
IONS Ionis Pharmaceuticals Inc | EC | 5,673 | $460,364 | 0.83% |
SRRK Scholar Rock Holding Corp | EC | 9,773 | $432,651 | 0.78% |
ASND Ascendis Pharma A/S | EC | 1,777 | $414,930 | 0.75% |
CRNX Crinetics Pharmaceuticals Inc | EC | 8,655 | $355,721 | 0.64% |
FXFXX First American Treasury Obligations Fund | STIV | 325,513 | $325,513 | 0.59% |
NBIX Neurocrine Biosciences Inc | EC | 2,387 | $315,681 | 0.57% |
ZEAL Zealand Pharma A/S | EC | 5,363 | $308,536 | 0.56% |
GUBRA Gubra A/S | EC | 4,545 | $281,026 | 0.51% |
NTLA Intellia Therapeutics Inc | EC | 14,076 | $193,967 | 0.35% |